Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor

By Yagihashi Soroku  

Brain, Vol. 124, Iss. 12, 2001-12 ,pp. : 2448-2458

Oxford University Press

Access to resources Recommend Favorite

The Absence of Synergism between the Effects of an Aldose Reductase Inhibitor, Epalrestat, and a Vasodilator, Cilostazol, on the Nerve Conduction Slowing and the Myelinated Fiber Atrophy in Streptozotocin-Induced Diabetic Rats

By Sasaki H.   Naka K.   Kishi Y.   Furuta M.   Sanke T.   Mukoyama M.   Nanjo K.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 466-470

Elsevier

Access to resources Recommend Favorite

Taurine Counteracts Oxidative Stress and Nerve Growth Factor Deficit in Early Experimental Diabetic Neuropathy

By Obrosova I.G.   Fathallah L.   Stevens M.J.  

Experimental Neurology, Vol. 172, Iss. 1, 2001-11 ,pp. : 211-219

Elsevier

Access to resources Recommend Favorite

Clinical trial of aldose reductase inhibitor (Epalrestat) in diabetic polyneuropathy: electrophysiological evaluation

By Katayama M.   Kaji R.   Kohara N.   Kojima Y.   Hirota N.   Kubori T.   Shibasaki H.   Kimura J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 81-81

Elsevier

Access to resources Recommend Favorite

Nerve Growth Factor (NGF) and Diabetic Neuropathy in the Rat: Morphological Investigations of the Sural Nerve, Dorsal Root Ganglion, and Spinal Cord

By Unger J.W.   Klitzsch T.   Pera S.   Reiter R.  

Experimental Neurology, Vol. 153, Iss. 1, 1998-09 ,pp. : 23-34

Elsevier

Access to resources Recommend Favorite